Amgen Inc
(FRA:AMG)
€
283.45
-18.25 (-6.05%)
Market Cap: 150.69 Bil
Enterprise Value: 198.90 Bil
PE Ratio: 38.26
PB Ratio: 21.34
GF Score: 90/100 Amgen Inc at Cowen Health Care Conference Transcript
Mar 08, 2023 / 04:10PM GMT
Release Date Price:
€217.4
(-0.71%)
Yaron Benjamin Werber
TD Cowen, Research Division - MD & Senior Biotechnology Analyst
Once again to the 43rd Annual Healthcare Conference, and it's actually the first TD Cowen Healthcare Conference. I'm Yaron Werber, biotech analyst here at TD Cowen. And it's a great pleasure to moderate the next fireside chat with Amgen, and the management really needs no introduction, all the way to at the left at the end is Peter Griffith, who's EVP and Chief Financial Officer; and to his right is Murdo Gordon, who's our EVP of Global Commercial Ops. Gentlemen, good to see you. Thank you so much for joining.
Peter H. Griffith
Amgen Inc. - Executive VP & CFO
Great to be here.
Yaron Benjamin Werber;Murdo Gordon
TD Cowen, Research Division - MD & Senior Biotechnology Analyst;Amgen Inc.
And for many of you who've been at the lobby, you can see there's actually a video. I'm talking about innovators in biotech and Murdo's on the video with us. We shot that at JPMorgan about 1.5 months ago.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot